![Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a406c5e5-3162-4e67-95a0-a2eb545f41e5/gr1_lrg.jpg)
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases
![Phase 1b Clinical trial of TG1050, a novel HBV-targeted immunotherapy, in NUC suppressed chronic hepatitis B patients: safety and early immunological data following single administration Phase 1b Clinical trial of TG1050, a novel HBV-targeted immunotherapy, in NUC suppressed chronic hepatitis B patients: safety and early immunological data following single administration](https://www.natap.org/2017/images/111017/111017-2/1110172.gif)
Phase 1b Clinical trial of TG1050, a novel HBV-targeted immunotherapy, in NUC suppressed chronic hepatitis B patients: safety and early immunological data following single administration
![JCI Insight - Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa JCI Insight - Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa](https://df6sxcketz7bb.cloudfront.net/manuscripts/130000/130554/medium/jci.insight.130554.t1.jpg)
JCI Insight - Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa
![EX-99.3 4 a17-19943_1ex99d3.htm EX-99.3 Exhibit 99.3 Company Overview We are a globally focused, clinical-stage biopharmaceutical company dedicated to becoming a leader in the discovery, development and commercialization of innovative ... EX-99.3 4 a17-19943_1ex99d3.htm EX-99.3 Exhibit 99.3 Company Overview We are a globally focused, clinical-stage biopharmaceutical company dedicated to becoming a leader in the discovery, development and commercialization of innovative ...](https://www.sec.gov/Archives/edgar/data/1651308/000110465917050784/g199431mei002.jpg)
EX-99.3 4 a17-19943_1ex99d3.htm EX-99.3 Exhibit 99.3 Company Overview We are a globally focused, clinical-stage biopharmaceutical company dedicated to becoming a leader in the discovery, development and commercialization of innovative ...
![Phase I trials as valid therapeutic options for patients with cancer | Nature Reviews Clinical Oncology Phase I trials as valid therapeutic options for patients with cancer | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41571-019-0262-9/MediaObjects/41571_2019_262_Fig1_HTML.png)
Phase I trials as valid therapeutic options for patients with cancer | Nature Reviews Clinical Oncology
![HIVinfo.NIH.gov on Twitter: "Phase 1 clinical trials are the first step in testing an experimental drug or other treatment in humans. A Phase 1 clinical trial only has around 20 to 80 HIVinfo.NIH.gov on Twitter: "Phase 1 clinical trials are the first step in testing an experimental drug or other treatment in humans. A Phase 1 clinical trial only has around 20 to 80](https://pbs.twimg.com/media/EfFHuLVXkAEROBW.jpg)
HIVinfo.NIH.gov on Twitter: "Phase 1 clinical trials are the first step in testing an experimental drug or other treatment in humans. A Phase 1 clinical trial only has around 20 to 80
![Understanding Clinical Trial Terminology: What's a Phase 1, 2 or 3 Clinical Trial? - Concert Pharmaceuticals Understanding Clinical Trial Terminology: What's a Phase 1, 2 or 3 Clinical Trial? - Concert Pharmaceuticals](https://www.concertpharma.com/wp-content/uploads/2019/09/9-3-19-Persepectives-blog-What-is-Phase-1-2-3-image-for-9-3-19-final-.jpg)
Understanding Clinical Trial Terminology: What's a Phase 1, 2 or 3 Clinical Trial? - Concert Pharmaceuticals
![Schematic of crossover experimental design for phase 1 clinical trial.... | Download Scientific Diagram Schematic of crossover experimental design for phase 1 clinical trial.... | Download Scientific Diagram](https://www.researchgate.net/profile/Chanchai-Boonla/publication/270965754/figure/fig1/AS:601680450166795@1520463206409/Schematic-of-crossover-experimental-design-for-phase-1-clinical-trial-Timed-heparinized.png)
Schematic of crossover experimental design for phase 1 clinical trial.... | Download Scientific Diagram
![A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3 A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3](https://ejgo.org/ArticleImage/1114JGO/jgo-30-e88-g001-l.jpg)
A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3
![PDF] Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug PDF] Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug](https://d3i71xaburhd42.cloudfront.net/f3aedb5d20e731efe213af1f3733f00ec267e1a6/2-Figure1-1.png)
PDF] Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug
![A phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine.,British Journal of Cancer - X-MOL A phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine.,British Journal of Cancer - X-MOL](https://xpic.x-mol.com/20190221%2F10.1038_s41416-018-0366-5.jpg)
A phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine.,British Journal of Cancer - X-MOL
![Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies - Annals of Oncology Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/4fbd2c57-dfa8-4450-b959-3e2174f9ad57/gr1.jpg)